ADHD (November)

Date of Issue: 11/01/2014 | Volume: 5 | Number: 6

Issue Links:Learning Objectives | Editorial Information

This double issue informs the clinician on the significance of a thorough assessment and evaluation in the diagnosis of ADHD in children and adolescents. It also discusses the role of current medications for treating ADHD, specifically Vyvanse and Intuniv.

In This Issue

Article

Vyvanse: A Look at America’s Most Prescribed Stimulant

Topics: ADHD | Child Psychiatry | Free Articles

Why has Vyvanse become by far the most prescribed stimulant in the United States? Great marketing? A great product? Some combination of the two?

Read More
Article

Intuniv: Exorbitant, Sedating, and Second-Line

Topics: ADHD | Child Psychiatry

Guanfacine, a drug originally used to treat hypertension, has been reformulated and now has new life as a medication to treat ADHD in children.

Read More
Expert Q&A

A Balanced Approach to Treating ADHD

Topics: ADHD | Child Psychiatry

Read about this balanced approach, including alternatives to medications, in treating children and adolescents with ADHD in an interview with pediatrician and author Lawrence Diller, MD.

Read More
Research Update

Pet Therapy for College Students

Topics: Anxiety Disorder | Research Updates

College can be a time of stress and loneliness for students. A new study shows that pet therapy may help ease the suffering.

Read More
Research Update

Danish Study Explains Most of Autism’s Rise

Topics: Autism Spectrum Disorder | Child Psychiatry | Research Updates

There is disagreement about the causes of this increased incidence of autism. Debate has focused on whether the rise in cases is an artifact caused by increased diagnosis and reporting, or if there is some unknown pathogenic factor in the environment that is causing an actual increase in new cases. A new study out of Denmark provides support for the artifact argument.

Read More
Research Update

To Prevent Depression in Teens, Teach about Change

Topics: Child Psychiatry | Depressive Disorder | Research Updates

Transitioning to high school can be a tough time, and studies have shown that teenagers are increasingly likely to have symptoms of depression over the course of their freshman year of school. Now an intriguing study seems to show that a simple intervention can ease these symptoms quite effectively.

Read More
Research Update

Daily Marijuana Use by Teens Creates Life Problems

Topics: Addiction | Child Psychiatry | Research Updates | Substance Abuse

A new study provides strong evidence that chronic marijuana use during adolescence can lead to significant social and psychiatric issues later in life.

Read More
News of Note

FDA Notice: Be Wary of Some Generic Versions of Concerta

Topics: ADHD | News of Note | Pharmaceutical Industry

Whether generics are really therapeutically equivalent to branded versions of drugs has long been controversial.

Read More
News of Note

Omega Fatty Acids Might Help Kids with Attention Deficits

Topics: ADHD | Child Psychiatry | News of Note

Given new research from Sweden, it won’t hurt—and might help—for clinicians to suggest their patients with attention deficit disorder (ADD) take supplements of the fatty acids omega 3 and 6.

Read More
News of Note

Pediatrician Policy Statement: Schools Should Start Later for Healthier Teens

Topics: Child Psychiatry | News of Note

School districts should move start times for middle and high schools to 8:30 a.m. or later, so that students can get at least 8.5 hours of sleep per night, according to the American Academy of Pediatrics.

Read More
News of Note

CDC Study: Kids Are Flocking to e-Cigarettes

Topics: Child Psychiatry | News of Note

More than a quarter-million middle school and high school students who had never smoked regular cigarettes used e-cigarettes in 2013, according to a study released by the US Centers for Disease Control and Prevention (CDC).

Read More
News of Note

Following Release from Prison, Suicide Risk Eighteen Times Higher

Topics: News of Note

A new study reveals that people who have been in prison run a higher risk of committing suicide, particularly just after their release.

Read More
News of Note

Debate Rages On Over ‘Black Box’ Warning on Antidepressants

Topics: Antidepressants | News of Note | Risk Management

The psychiatric community continues to debate the value of the US Food and Drug Administration's (FDA) so-called ‘black box’ warning on certain antidepressants, and a pair of opposing viewpoints was recently featured in the New England Journal of Medicine.

Read More